SEARCH

SEARCH BY CITATION

Reference

  • 1
    Arend WP, Dayer J-M: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 38: 151160, 1995
  • 2
    Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H, Woody JN: Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344: 11051110, 1994
  • 3
    Firestein GS, Zvaifler NJ: How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 33: 768772, 1990
  • 4
    Panayi GS, Lanchbury JS, Kingsley GH: The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 35: 729735, 1992
  • 5
    Fox DA: The role of T cells in the immunopathogenesis of rheumatoid arthritis: a new perspective. Arthritis Rheum 40: 598609, 1997
  • 6
    Firestein GS, Alvaro-Gracia J, Maki R: Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 144: 33473353, 1990
  • 7
    Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 383: 787793, 1996
  • 8
    Miossec P: Acting on the cytokine balance to control autoimmunity and chronic inflammation. Eur Cytokine Netw 4: 245251, 1993
  • 9
    Miossec P, Chomarat P, Dechanet J: Bypassing the antigen to control rheumatoid arthritis. Immunol Today 17: 170173, 1996
  • 10
    Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of activities and secreted proteins. J Immunol 136: 23482357, 1986
  • 11
    Mosmann TR, Schumacher JH, Street NF, Budd R, O'Garra A, Fong TAT, Bond MW, Moore KWM, Sher A, Fiorentino DF: Diversity of cytokine synthesis and function of mouse CD4 + T cells. Immunol Rev 123: 209229, 1991
  • 12
    Romagnani S: Human TH1 and TH2 subsets: doubt no more. Immunol Today 12: 256257, 1991
  • 13
    Del Prete GF, De Carli M, Mastromauro C, Biagiotti R, Macchia D, Falagiani P, Ricci M, Romagnani S: Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profiles of cytokine production. J Clin Invest 88: 346350, 1991
  • 14
    Miltenburg AMM, van Laar JM, de Kuiper R, Daha MR, Breedveld FC: T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand J Immunol 35: 603610, 1992
  • 15
    Quayle AJ, Chomarat P, Miossec P, Kjeldsen-Kragh J, Førre Ø, Natvig JB: Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (ThO-like) cytokine patterns. Scand J Immunol 38: 7582, 1993
  • 16
    Maggi E, Biswas P, Del Prete G, Parronchi P, Macchia D, Simonelli C, Emmi L, De Carli M, Tiri A, Ricci M, Romagnani S: Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol 146: 11691174, 1991
  • 17
    Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Morel-Fourrier B, Bronet J-C, Alarcón-Segovia D, Galanaud P, Emilie D: Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 181: 839844, 1995
  • 18
    Chomarat P, Kjeldsen-Kragh J, Quayle AJ, Natvig JB, Miossec P: Different cytokine production profiles of γδ T cell clones: relation to inflammatory arthritis. Eur J Immunol 24: 20872091, 1994
  • 19
    Chomarat P, Banchereau J, Miossec P: Differential effects of interleukins 10 and 4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis. Arthritis Rheum 38: 10461054, 1995
  • 20
    Dechanet J, Merville P, Durand I, Banchereau J, Miossec P: The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium. J Clin Invest 95: 456463, 1995
  • 21
    Hart PH, Jones CA, Finlay Jones JJ: Monocytes cultured in cytokine-defined environments differ from freshly isolated monocytes in their responses to IL-4 and IL-10. J Leukoc Biol 57: 909918, 1995
  • 22
    Isomäki P, Luukkainen R, Toivanen P, Punnonen J: The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis. Arthritis Rheum 39: 16931702, 1996
  • 23
    Zurawski SM, Chomarat P, Djossou O, Bidaud C, McKenzie AN, Miossec P, Banchereau J, Zurawski G: The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J Biol Chem 270: 1386913878, 1995
  • 24
    Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RJ: Human IL-17: a novel cytokine derived from T cells. J Immunol 155: 54835486, 1995
  • 25
    Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin JJ, Garrone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Das Mahapatra B, Rauvier E, Golstein P, Banchereau J, Lebecque S: T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183: 25932603, 1996
  • 26
    Daynes RA, Araneo BA, Dowell TA, Huang K. Dudley D: Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J Exp Med 171: 979996, 1990
  • 27
    Chomarat P, Rissoan M-C, Banchereau J, Miossec P: Interferon γ inhibits interleukin-10 production by monocytes. J Exp Med 177: 523527, 1993
  • 28
    Maggi E, Parronchi P, Manetti R, Simonelli C, Piccinni M-P, Rugiu FS, de Carli M, Ricci M, Romagnani S: Reciprocal regulatory effects of IFN-γ and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 148: 21422147, 1992
  • 29
    Szabo SJ, Dighe AS, Gubler U, Murphy KM: Regulation of the interleukin-12R β2 subunit expression in developing T helper 1 and Th2 cells. J Exp Med 185: 817824, 1997
  • 30
    Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DA, Doherty PC, Grosveld GS, Ihle JN: Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382: 171174, 1996
  • 31
    Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, McKnight SL: An interleukin-4-induced transcription factor: IL-4 Stat. Science 265: 17011706, 1994
  • 32
    Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S: Essential role of stat6 in IL-4 signalling. Nature 380: 627630, 1996
  • 33
    Tortorella C, Schulze-Koops H, Thomas R, Splawski JB, Davis LS, Picker LJ, Lipsky PE: Expression of CD45RB and CD27 identifies subsets of CD4 + memory T cells with different capacities to induce B cell differentiation. J Immunol 155: 149162, 1995
  • 34
    Kohem CL, Brezinschek RI, Wisbey H, Tortorella C, Lipsky PE, Oppenheimer-Marks N: Enrichment of differentiated CD45RBdim, CD27- memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 39: 844854, 1996
  • 35
    Zheng W, Flavell RA: The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89: 587596, 1997
  • 36
    Gause WC, Urban JF, Linsley P, Lu P: Role of B7 signaling in the differentiation of naive CD4 + T cells to effector interleukin-4-producing T helper cells. Immunol Res 14: 176188, 1995
  • 37
    Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T cell costimulation. Annu Rev Immunol 14: 233258, 1996
  • 38
    Rulifson IC, Sperling AI, Fields PE, Fitch FW, Bluestone JA: CD28 costimulation promotes the production of Th2 cytokines. J Immunol 158: 658665, 1997
  • 39
    Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N, Herold KC, Bluestone JA: Differential effects of anti-B7–1 and anti-B7–2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 181: 11451155, 1995
  • 40
    Khoury SJ, Akalin E, Chandraker A, Turka LA, Linsley PS, Sayegh MH, Hancock WW: CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J Immunol 155: 45214524, 1995
  • 41
    Natesan M, Razi Wolf Z, Reiser H: Costimulation of IL-4 production by murine B7–1 and B7–2 molecules. J Immunol 156: 27832791, 1996
  • 42
    Freeman GJ, Boussiotis VA, Anumanthan A, Bernstein GM, Ke XY, Rennert PD, Gray GS, Gribben JG, Nadler LM: B7–1 and B7–2 do not deliver identical costimulatory signals, since B7–2 but not B7–1 preferentially costimulates the initial production of IL-4. Immunity 2: 523532, 1995
  • 43
    Miossec P, Elhamiani M, Chichehian B, Dupuy d'Angeac A, Sany J. Hirn M: Interleukin 2 (IL-2) inhibitor in rheumatoid synovial fluid: correlation with prognosis and soluble IL-2 receptor levels. J Clin Immunol 10: 115120, 1990
  • 44
    Chen E, Keystone EC, Fish EN: Restricted cytokine expression in rheumatoid arthritis. Arthritis Rheum 36: 901910, 1993
  • 45
    Miossec P, Briolay J, Dechanet J, Wijdenes J, Martinez-Valdez H, Banchereau J: Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis. Arthritis Rheum 35: 874883, 1992
  • 46
    Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M: Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 179: 15171527, 1994
  • 47
    Yssel H, Shanafelt M-C, Soderberg C, Schneider PV, Anzola J, Peltz G: Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J Exp Med 174: 593601, 1991
  • 48
    Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL: Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254: 277279, 1991
  • 49
    Haanen JBAG, de Waal Malefyt R, Res PCM, Kraakman EM, Ottenhoff THM, de Vries RRP, Spits H: Selection of a human T helper type 1-like T cell subset by mycobacteria. J Exp Med 174: 583592, 1991
  • 50
    Iwakura Y, Tosu M, Yoshida E: Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-1. Science 253: 10261028, 1991
  • 51
    Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D: Organ-specific disease provoked by systemic autoimmunity. Cell 87: 811822, 1996
  • 52
    Austrup F, Vestweber D, Borges E, Lohning M, Brauer R, Herz U, Renz H, Hallmann R, Scheffold A, Radbruch A, Hamann A: P-and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 385: 8183, 1997
  • 53
    Kavanaugh AF, Davis LS, Nichols LA, Norris SH, Rothlein R, Scharschmidt LA, Lipsky PE: Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum 37: 992999, 1994
  • 54
    Meeusen EN, Premier RR, Brandon MR: Tissue-specific migration of lymphocytes: a key role for Th1 and Th2 cells? Immunol Today 17: 421424, 1996
  • 55
    Al Janadi M, Al Dalaan A, Al Balla S, Raziuddin S: CD4 + T cell inducible immunoregulatory cytokine response in rheumatoid arthritis. J Rheumatol 23: 809814, 1996
  • 56
    Chomarat P, Briolay J, Banchereau J, Miossec P: Increased production of soluble CD23 in rheumatoid arthritis and its regulation by interleukin-4. Arthritis Rheum 36: 234242, 1993
  • 57
    Jacobs MJM, van den Hoek AEM, van Lent P, van de Loo FAJ, van de Putte LBA, van den Berg WB: Role of IL-2 and IL-4 in exacerbations of murine antigen-induced arthritis. Immunology 83: 390396, 1994
  • 58
    Kasama T, Strieter RM, Lukacs NW, Lincoln PM, Burdick MD, Kunkel SL: Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest 95: 28682876, 1995
  • 59
    Joosten LAB, Lubberts E, Durez P, Helsen MMA, Jacobs MJM, Goldman M, van den Berg W: Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis: protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 40: 249260, 1997
  • 60
    Crisi GM, Santambrogio L, Hochwald GM, Smith SR, Carlino JA, Thorbecke GJ: Staphylococcal enterotoxin B and tumor-necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-beta and interleukin-10. Eur J Immunol 25: 30353040, 1995
  • 61
    Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W: Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263274, 1993
  • 62
    Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693699, 1992
  • 63
    Walmsley M, Katsikis PD, Abney E, Parry S, Williams RO, Maini RN, Feldmann M: Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum 39: 495503, 1996
  • 64
    Yeh LA, Augustine AJ, Lee P, Riviere LR, Sheldon A: Interleukin-4, an inhibitor of cartilage breakdown in bovine articular cartilage explants. J Rheumatol 22: 17401746, 1995
  • 65
    Murphy E, Shibuya K, Hosken N, Openshaw P, Maino V, Davis K, Murphy K, O'Garra A: Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J Exp Med 183: 901913, 1996
  • 66
    Germann T, Szeliga J, Hess H, Storkel S, Podlaski FJ, Gately MK, Schmitt E, Rude E: Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc Natl Acad Sci U S A 92: 48234827, 1995
  • 67
    Joosten LAB, Helsen MMA, van den Berg WB: Dual role of interleukin-12 in early and late stages of murine collagen type I arthritis. J Immunol (in press)
  • 68
    Prakken BJ, van der Zee R, Anderton SM, van Kooten P, Kuis W, van Eden W: Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T-cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis. Proc Natl Acad Sci U S A 94: 32843289, 1997
  • 69
    Weiner HL, Miller A, Khoury SJ, Zhang ZJ, al Sabbagh A, Brod SA, Lider O, Higgins P, Sobel R, Matsui M: Treatment of autoimmune diseases by oral tolerance to autoantigens. Adv Exp Med Biol 371B: 12171223, 1995
  • 70
    Tian J, Atkinson MA, Clare Salzler M, Herschenfeld A, Forsthuber T, Lehmann PV, Laufman DL: Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 183: 15611567, 1996
  • 71
    Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL: A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4 + T cells. J Exp Med 183: 26692674, 1996
  • 72
    Nicholson LB, Greer JM, Sobel RA, Lees MB, Kuchroo VK: An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3: 397405, 1995
  • 73
    Chu CQ, Londei M: Induction of Th2 cytokines and control of collagen-induced arthritis by nondepleting anti-CD4 Abs. J Immunol 157: 26852689, 1996
  • 74
    Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS, Shevach EM, Röcken M: Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 180: 19611966, 1994
  • 75
    Al Sabbagh A, Nelson PA, Akselband Y, Sobel RA, Weiner HL: Antigen-driven peripheral immune tolerance: suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen. Cell Immunol 171: 111119, 1996
  • 76
    Khare SD, Krco CJ, Griffiths MM, Luthra HS, David CS: Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. J Immunol 155: 36533659, 1995
  • 77
    Chomarat P, Vannier E, Dechanet J, Rissoan MC, Banchereau J, Dinarello CA, Miossec P: Balance of IL-1 receptor antagonist/IL-1β in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol 154: 14321439, 1995
  • 78
    Miossec P, Chomarat P, Dechanet J, Moreau J-F, Roux J-P, Delmas P, Banchereau J: Interleukin 4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. Arthritis Rheum 37: 17151722, 1994
  • 79
    Van Roon JAG, van Roy J, Duits A, Lafeber F, Bijlsma JWJ: Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4. Ann Rheum Dis 54: 836840, 1995
  • 80
    Dechanet J, Rissoan MC, Banchereau J, Miossec P: Interleukin 4, but not interleukin 10, regulates the production of inflammation mediators by rheumatoid synoviocytes. Cytokine 7: 176183, 1995
  • 81
    Dechanet J, Taupin JL, Chomarat P, Rissoan MC, Moreau JF, Banchereau J, Moissec P: Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes. Eur J Immunol 24: 32223228, 1994
  • 82
    Rocken M, Racke M, Shevach EM: IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol Today 17: 225231, 1996
  • 83
    Bessis N, Boissier MC, Ferrara P, Blankenstein T, Fradelizi D, Fournier C: Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur J Immunol 26: 23992403, 1996
  • 84
    Formby B: Immunologic response in pregnancy: its role in endocrine disorders of pregnancy and influence on the course of maternal autoimmune diseases. Endocrinol Metab Clin North Am 24: 187205, 1995
  • 85
    Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 14: 353356, 1993
  • 86
    Nelson JL, Hughes KA, Smith AG, Nisperos BB, Branchaud AM, Hansen JA: Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 329: 466471, 1993
  • 87
    Arasil TK, Tuncer S, Tosun M: Sustained remission of rheumatoid arthritis following hypersensitivity reaction (letter). Arthritis Rheum 34: 789790, 1991
  • 88
    Calabrese LH, Wilke WS, Perkins AD, Tubbs RR: Rheumatoid arthritis complicated by infection with the human immunodeficiency virus and the development of Sjögren's syndrome. Arthritis Rheum 32: 14531457, 1989
  • 89
    Marmont AM: Immune ablation followed by allogeneic or autologous bone marrow transplantation: a new treatment for severe autoimmune disease? Stem Cells 12: 125135, 1994
  • 90
    Meyaard L, Hovenkamp E, Keet IP, Hooibrink B, de Jong IH, Otto SA, Miedema F: Single cell analysis of IL-4 and IFN-gamma production by T cells from HIV-infected individuals: decreased IFN-gamma in the presence of preserved IL-4 production. J Immunol 157: 27122718, 1996
  • 91
    Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, Hafler DA, Weiner HL: Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261: 17271730, 1993
  • 92
    Sieper J, Kary S, Sörensen H, Alten R, Eggens U, Hüge W, Hiepe F, Kühne F, Listing J, Ulbrich N, Braun J, Zink A, Mitchison NA: Oral type II collagen treatment in early rheumatoid arthritis: a double-blind, placebo-controlled, randomized trial. Arthritis Rheum 39: 4151, 1996
  • 93
    Firestein GS, Nguyen K, Aupperle KR, Yeo M, Boyle DL, Zvaifler NJ: Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 149: 21432151, 1996